Different renal phenotypes in related adult males with Fabry disease with the same classic genotype
- PMID: 28717668
- PMCID: PMC5511792
- DOI: 10.1002/mgg3.292
Different renal phenotypes in related adult males with Fabry disease with the same classic genotype
Abstract
Background: Fabry disease related patients with classical mutation usually exhibit similar severe phenotype especially concerning renal manifestation.
Methods: A dry blood spot screening (DBS) and the DNA analysis has been performed in a 48-year-old man (Patient 1) because of paresthesia.
Results: The DBS revealed absent leukocyte α-Gal A enzyme activity while DNA analysis identified the I354K mutation. Serum creatinine and e-GFR were in normal range and also albuminuria and proteinuria were absent. The brain MRI showed ischemic lesions and a diffuse focus of gliosis in the white matter, while the echocardiogram showed a left ventricular hypertrophy. The renal biopsy performed in the case index showed a massive deposition of zebra bodies. By a familiar investigation, it was recognized that his brother (Patient 2) died 2 years before from sudden death syndrome at the age of 49. He had suffered sporadic and undiagnosed pain at the extremities, a prior cataract, bilateral neurosensorial hearing loss and left ventricular hypertrophy on Echocardiogram. His previous laboratory examinations revealed a normal serum creatinine and the absence of proteinuria. Pedigree analysis of the brothers revealed a high disease burden among family members, with an affected cousin (Patient 3) who progressed early to end-stage renal disease (ESRD) that required renal transplantation.
Conclusions: Here we describe the clinical history of three adult male members of the same family with the same genotype who manifested different presentation and progression of the disease, particularly concerning the renal involvement.
Keywords: Fabry disease; genotype; mutation; phenotype; proteinuria; variability.
Figures
Similar articles
-
Discordant renal progression of Fabry disease in male monozygotic twins: a case report.Front Genet. 2023 Jun 14;14:1150822. doi: 10.3389/fgene.2023.1150822. eCollection 2023. Front Genet. 2023. PMID: 37388940 Free PMC article.
-
Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.Kidney Int. 2003 Sep;64(3):801-7. doi: 10.1046/j.1523-1755.2003.00160.x. Kidney Int. 2003. PMID: 12911529
-
A missense mutation, A156T, in the alpha-galactosidase A gene causes typical Fabry disease.Clin Nephrol. 2001 Mar;55(3):243-7. Clin Nephrol. 2001. PMID: 11316246
-
[Fabry disease in light of recent review].Brain Nerve. 2008 Nov;60(11):1235-44. Brain Nerve. 2008. PMID: 19069157 Review. Japanese.
-
Renal involvement in Anderson-Fabry disease.J Nephrol. 2003 Mar-Apr;16(2):310-3. J Nephrol. 2003. PMID: 12774774 Review.
Cited by
-
Screening of Fabry disease in patients with chronic kidney disease in Japan.Nephrol Dial Transplant. 2021 Dec 31;37(1):115-125. doi: 10.1093/ndt/gfaa324. Nephrol Dial Transplant. 2021. PMID: 34282462 Free PMC article.
-
A classic variant of Fabry disease in a family with the M296I late-onset variant.CEN Case Rep. 2021 Feb;10(1):106-110. doi: 10.1007/s13730-020-00527-0. Epub 2020 Sep 9. CEN Case Rep. 2021. PMID: 32902816 Free PMC article.
-
Discordant renal progression of Fabry disease in male monozygotic twins: a case report.Front Genet. 2023 Jun 14;14:1150822. doi: 10.3389/fgene.2023.1150822. eCollection 2023. Front Genet. 2023. PMID: 37388940 Free PMC article.
-
Mutation spectrum of α-Galactosidase gene in Japanese patients with Fabry disease.J Hum Genet. 2019 Jul;64(7):695-699. doi: 10.1038/s10038-019-0599-z. Epub 2019 Apr 15. J Hum Genet. 2019. PMID: 30988410
-
The Role of Kidney Biopsy in Fabry Disease.Biomedicines. 2025 Mar 21;13(4):767. doi: 10.3390/biomedicines13040767. Biomedicines. 2025. PMID: 40299366 Free PMC article. Review.
References
-
- Desnick, R. J. , Ioannou Y. A., and Eng M. E.. 2001. α‐Galactosidase A deficiency: fabry disease Pp 3733–3774 in Scriver C. R., Beaudet A. L., Sly W. S., Valle D. (eds). The metabolic and molecular bases of inherited disease. 8th ed Vol 3 McGraw‐Hill: New York.
-
- Echevarria, L. , Benistan K., Toussaint A., Dubourg O., Hagege A. A., Eladari D., et al. 2016. X‐chromosome inactivation in female patients with Fabry disease. Clin. Genet. 89:44–54. - PubMed
-
- Hsu, T. R. , Hung S. C., Chang F. P., Yu W. C., Sung S. H., Hsu C. L., et al. 2016. Later onset Fabry disease, cardiacdamage progress in silence: experience with a highly prevalent mutation. J. Am. Coll. Cardiol. 68:2554–2563. - PubMed
-
- Mignani, R. , Feriozzi S., Pisani S., et al. 2008. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol. Dial. Transplant. 23:1628–1635. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous